Literature DB >> 19184118

Streptococcal zymogen type B induces angiotensin II in mesangial cells and leukocytes.

Ninoska Viera1, Adriana Pedreanez, Jaimar Rincon, Jesus Mosquera.   

Abstract

Previous reports have shown that angiotensin II and oxidative stress may be important features in acute poststreptococcal glomerulonephritis (APSGN) and that streptococcal erythrogenic toxin type B (ETB) and its precursor (ETBP) may have an important role in the pathogenesis of APSGN. The aim of this study was to determine the effect of ETBP on the production of angiotensin II and oxidative stress in rat mesangial cells and human mononuclear leukocytes. Mesangial cells and leukocytes were isolated from digested glomeruli and by histopaque gradient, respectively, while ETBP was isolated from nephritogenic streptococcus cultures using a cation exchange column. Angiotensin II was determined by an enzyme-linked immunosorbent assay and by cytometrics. Superoxide anion, reduced glutathione, nitrites, lipid peroxidation and catalase activity were determined by cytochemical, biochemical and enzymatic assays. Inducible nitric oxide synthase expression was determined by cytometrics. An increased production of angiotensin II was observed in ETBP-treated mesangial cell and leukocyte cultures. The ETBP induced an elevated production of superoxide anions and nitrites in mesangial cells and superoxide anions in leukocytes, while this streptococcal protein decreased the expression of inducible nitric oxide synthase in leukocytes. The ETBP was capable of inducing an increased production of angiotensin II and increased oxidative stress, both of which may be important mediators of inflammatory events in the renal tissue and during APSGN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184118     DOI: 10.1007/s00467-008-1105-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  35 in total

1.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

Authors:  H Ohkawa; N Ohishi; K Yagi
Journal:  Anal Biochem       Date:  1979-06       Impact factor: 3.365

2.  Transient encephalopathy complicating poststreptococcal glomerulonephritis in an adult with diagnostic findings consistent with cerebral vasculitis.

Authors:  Martin Ritt; Valentina Campean; Kerstin Amann; Annette Heider; Daniela Griesbach; Roland Veelken
Journal:  Am J Kidney Dis       Date:  2006-09       Impact factor: 8.860

3.  Lipid peroxidation in IgA nephropathy and the effect of lipo-prostaglandin E1.

Authors:  Jiong Tian; Jiang H Chen; Qun Li; Qiang He; Wei Q Lin
Journal:  J Nephrol       Date:  2005 May-Jun       Impact factor: 3.902

4.  Posterior reversible encephalopathy syndrome revealing acute post-streptococcal glomerulonephritis.

Authors:  Alec Aeby; Philippe David; Christophe Fricx; Patrice Jissendi; Serge Blecic; Patrick Van Bogaert
Journal:  J Child Neurol       Date:  2006-03       Impact factor: 1.987

5.  Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms.

Authors:  M Ruiz-Ortega; O Lorenzo; M Rupérez; S König; B Wittig; J Egido
Journal:  Circ Res       Date:  2000-06-23       Impact factor: 17.367

6.  Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?

Authors:  Stephen R Batsford; Sergio Mezzano; Michael Mihatsch; Emile Schiltz; Bernardo Rodríguez-Iturbe
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

7.  Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.

Authors:  Matthew C Zimmerman; Eric Lazartigues; Ram V Sharma; Robin L Davisson
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

8.  Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study.

Authors:  G Parra; B Rodríguez-Iturbe; S Batsford; A Vogt; S Mezzano; F Olavarría; R Exeni; M Laso; N Orta
Journal:  Kidney Int       Date:  1998-08       Impact factor: 10.612

9.  Short-term treatment with captopril in hypertension due to acute glomerulonephritis.

Authors:  G Parra; B Rodríguez-Iturbe; J Colina-Chourio; R García
Journal:  Clin Nephrol       Date:  1988-02       Impact factor: 0.975

10.  Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis.

Authors:  M R Morsi; E H Madina; A A Anglo; A T Soliman
Journal:  Acta Paediatr       Date:  1992-02       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.